Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
06/2003
06/26/2003US20030119673 Phenylpyridazinones
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114459 Synergistic mixture with prostaglandins; analgesics
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1319659A1 Pyridazinones and triazinones and medicinal use thereof
06/18/2003EP1318974A2 Resorcinol derivatives
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003045923A1 Preventives or remedies for alzheimer’s disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003US20030105328 High effectiveness and high oral bioavailability; for example, 6-(4-Acetamidophenyl)-3-isobutyryl-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxoquinoline
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
06/05/2003US20030105101 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/04/2003CN1422272A Pyrrolopyridazine compound
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110485C 1-arylsulphonyl, aryl (thio) Carbonyl pyridazino derivatives and producing process thereof
06/04/2003CN1110478C Biocidal benzylbiphenyl derivatives
05/2003
05/29/2003US20030100560 Such as 2,3-dimethoxy-dibenzo(c,h)cinnoline for treatment of cancer; fungicides
05/28/2003EP1313704A2 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/22/2003WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1311497A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
05/21/2003CN1109022C Arylalkanoyl pyridazines derivatives, its preparation method, medicine comprising samd and use thereof
05/21/2003CN1109018C Systhesis of hydrazone beta-keto ester by reaction with diazo ester
05/20/2003CA2117059C Pyrido-pyridazinone and pyridazinthione compounds
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039548A1 Hydrazono-malonitriles
05/15/2003WO2003039451A2 Thiazole pyridazinones as adenosine antagonists
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003CN1418196A Pyridazinyl phenyl hydrazones useful against congestive heart failure
05/13/2003US6562817 Suppressants of the IgE production
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003US20030087151 Low melting point
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/07/2003EP1307444A2 Substituted heterocyclic amides
05/07/2003EP1058681B1 Novel allylthiopyridazine derivatives and process for preparing the same
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1415606A Method of preparing compound of 0-substituted sulphonyl propylhomoserin class
05/02/2003EP1034166B1 Substituted 2-phenyl-3(2h)-pyridazinones
05/02/2003EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003CA2463290A1 Zwitterionic imides
04/2003
04/29/2003USRE38102 Use of a pyridazinone derivative
04/29/2003US6555663 Prodrugs for selective drug delivery
04/24/2003WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003WO2003032993A1 Use of phosphorodiesterase iv inhibitors
04/24/2003US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
04/24/2003US20030078267 Oxidation of a dihydro-pyrazolopyridazine
04/24/2003US20030078266 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients
04/24/2003US20030077405 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices
04/24/2003CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/23/2003EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
04/23/2003CN1413215A Process for preparation of pyrazolo pyridazine derivatives
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1106371C Liquid crystal compounds having perfluoroether terminal portions
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6551963 For controlling unwanted vegetation
04/17/2003WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
04/17/2003WO2003006454A3 Heterocyclic carboxamides and their use as fungicides
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/15/2003US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms
04/10/2003WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
04/09/2003EP1300399A1 Phenylpyridazine derivatives and drugs containing the same
04/09/2003EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
04/08/2003US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
04/08/2003US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation
04/03/2003WO2003027097A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
04/03/2003WO2003027078A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
04/03/2003WO2003027077A1 Water-soluble phenylpyridazine derivatives and drugs containing the same
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003CA2461806A1 Water-soluble phenylpyridazine derivatives and medicines containing the same
04/03/2003CA2461467A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
04/02/2003EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
04/02/2003EP1228069B1 Bicyclic and tricyclic heteroaromatic compounds
04/02/2003EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
04/02/2003EP0946520B1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/01/2003US6541473 Resorcinol derivatives
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 85